Risk–benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.3, Iss.3, 2004-05, pp. : 231-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting

By Ruhlmann Christina H Herrstedt Jøørn

Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. : 449-462

Informa Healthcare

Access to resources Recommend Favorite

Aprepitant: A Review of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting

By Dando T.M. Perry C.M.

Drugs, Vol. 64, Iss. 7, 2004-01 ,pp. : 777-794

Adis International

Access to resources Recommend Favorite

Tropisetron: An Update of its Use in the Prevention of Chemotherapy-Induced Nausea and Vomiting

By Simpson K. Spencer C.M. McClellan K.J.

Drugs, Vol. 59, Iss. 6, 2000-06 ,pp. : 1297-1315

Adis International

Access to resources Recommend Favorite

Options for the Prevention and Management of Acute Chemotherapy-Induced Nausea and Vomiting in Children

By Dupuis L.L. Nathan P.C.

Pediatric Drugs, Vol. 5, Iss. 9, 2003-01 ,pp. : 597-613

Adis International

Access to resources Recommend Favorite

Palonosetron for chemotherapy-induced nausea and vomiting

Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite